Prevention of Cancer Therapy-Related Cardiac Dysfunction

Thursday, 22 October 2026 · 9:00 AM EDT | 3:00 PM CEST

Join Dr Joe Carver (University of Pennsylvania, Philadelphia, US), Dr Dan Lenihan (Saint Francis Healthcare System, Cape Girardeau, US), Dr Colin Aspelund (Chapel Hill Eshelman School of Pharmacy, Chapel Hill, US), Dr Suphat Subongkot (Khon Kaen University, Khon Kaen, TH) and Dr Joshua Bennetts (University of Newcastle, Newcastle, AU) where they will discuss Prevention and Management of Cancer Therapy-Related Cardiac Dysfunction: What's New? This webinar is in collaboration with IC-OS and ISCP.

This webinar is for cardiologists, haematologists, oncologists, nurse practitioners, nurses and pharmacists.

The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimising the cardiac status of patients with cancer before, during and after their treatment, IC-OS is collectively improving the overall outcomes including survival and quality of life. IC-OS aims to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection.

Learning Objectives

• Current landscape of evidence and updates on cardioprotective pharmacotherapies

• Guideline recommendations for risk stratification and prevention of CTRCD

• Application of guidelines to specific populations

• Real-world integration of clinical guidelines through case study

Target Audience

Cardiologists, oncologists, pharmacists, haematologists, general practitioners, nurses and allied health professionals.

Organised in collaboration with the International Cardio-Oncology Society (IC-OS): https://ic-os.org